Sondra Newman Email Address

Vice President and Global Head of Investor Relations

Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies.

Investor relations leader with 20 years of experience supporting U.S. publicly traded companies. Efficiently establishes and implements investor communications strategies to guide proper valuation, ensure regulatory compliance and articulate corporate sustainability initiatives. Excellent client service history as both an internal and agency provider. Proven aptitude for distilling complex financial, technical and/or scientific subject matter into comprehensive audience-specific messages. Demonstrated ability to establish, nurture and leverage relationships across internal disciplines and with external stakeholders. Exceptional organizational, communications and analytical skills. Extensive well-established network in the investment banking, sellside research and institutional investment communities.